Showing results (1021-1030 of 1,122) with videos related to
Sort By:
Pageof 113
Cancer Genetics|August 20, 2019
RUNX1 deletion/amplification in therapy-related acute myeloid leukemia: A case report and review of the literatureDavid Nguyen, Yuwen Li, Hana Safah, et al.Cancer Genetics|August 20, 2019
Telomere length measurement in tumor and non-tumor cells as a valuable prognostic for tumor progressionFatma Mehrez, Karim Bougatef, Elisa Delle Monache, et al.Cancer Genetics|August 20, 2019
Cytogenomic characterization of double minute heterogeneity in therapy related acute myeloid leukemiaPrasad Koduru, Weina Chen, Barbara Haley, et al.Cancer Genetics|August 27, 2019
PD-L1 gene copy number and promoter polymorphisms regulate PD-L1 expression in tumor cells of non-small cell lung cancer patientsPaweł Krawczyk, Anna Grenda, Kamila Wojas-Krawczyk, et al.Cancer Genetics|August 27, 2019
Association of transcriptional levels of folate-mediated one-carbon metabolism-related genes in cancer cell lines with drug treatment responseDong-Joon Min, Suleyman Vural, Julia KrushkalCancer Genetics|August 27, 2019
Inherited cancer syndromes in 220 Italian ovarian cancer patientsI Carnevali, C Riva, A M Chiaravalli, et al.Cancer Genetics|August 27, 2019
Concurrent chromothripsis events in a case of TP53 depleted acute myeloid leukemia with myelodysplasia-related changesD Tolomeo, A L'Abbate, A Lonoce, et al.Cancer Genetics|August 27, 2019
Single-cell cloning of human T-cell lines reveals clonal variation in cell death responses to chemotherapeuticsKathleen Hanlon, Alex Thompson, Lorena Pantano, et al.Cancer Genetics|August 27, 2019
Non-invasive genotyping of metastatic colorectal cancer using circulating cell free DNAXuemei Shi, Dzifa Y Duose, Meenakshi Mehrotra, et al.Cancer Genetics|August 27, 2019
Prevalence and founder effect of the BRCA1 p.(Val1833Met) variant in the Greek population, with further evidence for pathogenicity and risk modificationMyrto Papamentzelopoulou, Paraskevi Apostolou, Florentia Fostira, et al.Pageof 113